Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Royal Dutch Shell plc (ADR) (RDS.A): Is This a Shell Game, or Reality?

An otherwise active week of news among some of the biggest companies in the markets, the week in trading seemed to end with another pretty significant headline, and it was more for new that is coming.

Royal Dutch Shell plc (ADR) (NYSE:RDS-A)

A warning shot, and it comes courtesy of Royal Dutch Shell plc (ADR) (NYSE:RDS.A), which announced Friday in a warning to analysts and investors that its four quarter earnings report may likely show a significant profit miss from what the Street had predicted. CNBC had coverage of the story Friday, providing two segments of analysis about this.

The first one, from RBC Capital Markets analyst Peter Hutton, said this warnign by Royal Dutch Shell plc (ADR) (NYSE:RDS.A) is not really new information, but a reminder to the Street. Hutton commented that the question here is whether the profit miss is an underlying item in the report, or if it’s a one-time item that is normally stripped out for analysts to see the general health of the balance sheet. So far, there was no indication  which is the cause of this expected miss.

In the second clip from CNBC, Chris Tinker of Libra Investment Services discussed Royal Dutch Shell plc (ADR) (NYSE:RDS.A) and comments that this announcement by the company may fall under the heading of “reality check.” Tinker said his firm sent out a sell notice to its investors, which surprised some and went against the conventional thought about the company, and Tinker claimed that the fundamentals of Royal Dutch Shell plc (ADR) (NYSE:RDS.A) were a factor in the rating.

Here is Tinker’s segment:

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!